SENSEX 28463.31 17.19 0.06% NIFTY 8609.85 Finalaya.com, 1 week ago
Panacea Biotec reappoints Sumit Jain as whole-time director - Money Control, 1 week ago
Board of Panacea Biotec appoints CFO and KMP - HDFC Securities, 2 months ago
The pharmaceutical companies in India, particularly the homegrown players, are yet to catch up with the usage of digital media in terms of presence and engagement even as the healthcare practitioners are using internet as a prominent tool to access ...Smart Investor, 1 week ago
Research and Markets (http://www.researchandmarkets.com/research/75dq35/diphtheria) has announced the addition of the "Diphtheria - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic ...Individual.com, 1 week ago Haemophilus Influenzae Type b Infections Therapeutics Pipeline Review, H1 2015 - 11 Companies & 16 Drug Profiles Individual.com, 1 week ago Research and Markets: Diphtheria Therapeutics Pipeline Report 2015 - 14 Companies & 21 Drug Profiles Reuters, 1 week ago RESEARCH AND MARKETS : Diphtheria Therapeutics Pipeline Report 2015 - 14 Companies & 21 Drug Profiles 4 Traders, 1 week ago
Investments in shares of pharmaceutical companies is considered to be relatively safe as compared to other industry segments in the country, but in recent years that scenario has changed dramatically. Scrips of quite a few pharma companies are ...PharmaBiz, 1 week ago
Diphtheria Pipeline Products and Comparative Analysis with Company Profiles Research Report Available at RnRMarketResearch.com
PRWeb The report "Neutropenia - Pipeline Review, H1 2015" provides comparative analysis on the therapeutic development for Neutropenia. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and ...Town Hall, 2 weeks ago Psoriatic Arthritis Therapeutic Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com CEOWorld Magazine, 3 weeks ago Wegener's Granulomatosis Therapeutic Companies and Drugs Pipeline Review H1 2015 Research Report Wall Street Select, 1 month ago
DoP rejects Panacea Biotec's review plea against price revision of 'amphotericin B injection (50 mg)'
The department of pharmaceuticals (DoP) has rejected the review application of Panacea Biotec against fixation/revision of retail price of scheduled medicine 'amphotericin B injection (50 mg)' by the national drug regulator National Pharmaceutical ...PharmaBiz, 2 weeks ago
Panacea Biotec Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Panacea Biotec Limited - Product Pipeline Review - 2014', (http://www.radiantinsights.com/research/panacea-biotec-limited-product-pipeline-review-2014) ...Bloomberg, 1 month ago Panacea Biotec Limited - Product Pipeline Review - 2014 Individual.com, 1 month ago
Research and Markets has announced the addition of the "Psoriatic Arthritis - Pipeline Review, H1 2015" report to its offerings. In a release, Research and Markets noted that report highlights include: This report provides comprehensive ...Individual.com, 2 weeks ago Research and Markets Adds Report: Japanese Encephalitis - Pipeline Review, H1 2015 Individual.com, 4 weeks ago Research and Markets Adds Report: Yellow Fever - Pipeline Review, H1 2015 Individual.com, 1 month ago
Listed below are all new filings before PTAB of requests for inter partes review (IPR) and covered business methods review (CBM). Also listed are any newly-posted requests for ex parte reexamination at the USPTO. This listing is current as of 9:45 ...National Law Review, 1 month ago
/PRNewswire/ -- This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs, and ...Marketplace, 1 month ago
on your WebpageAdd Widget >Get your members hooked!